Precision Medicine

Under the agreement, Covance will join Tempus’ TIME Trial Network, a data-driven approach that aims to improve the efficiency of clinical trials recruitment, design, and launch.

Sponsor: IlluminaIn this Clinical OMICs KEYNOTE webinar, sponsored by Illumina, we are delighted to host two true pioneers of clinical genome sequencing, bioinformatician Dr. Liz Worthey and geneticist Dr. Howard Jacob, who will reflect on a decade of progress in clinical genome analysis and discuss the future challenges confronting the field.

AstraZeneca and the University of Oxford resumed the clinical study they paused last week after one U.K. participant developed a “potentially unexplained illness,” while Pfizer and BioNTech have requested FDA approval to add 14,000 participants to their late-stage study.

The new partnerships are intended to bolster Thermo Fisher's Precision Medicine Science Center's mission of creating standardized workflows with pharma and academic partners, with the goal of enhancing precision medicine by streamlining the transition from biomarker research to clinical implementation.

Unlike children with Kawasaki disease and children with mild COVID-19, children who developed MIS-C were lacking IgG-antibodies to common cold coronaviruses. The researchers also found several autoantibodies that target the body’s own proteins and that may contribute to the pathogenesis of MIS-C.

The company is currently testing whether its engineered antibody or “Humaneered” technology developed over two decades can catapult the company to a leading role in the scramble to conquer COVID-19.

Sherlock’s SARS-CoV-2 test kit has received Emergency use Authorization from the FDA and is designed for use in CLIA labs certified for performing high complexity tests.

The Centers for Research in Emerging Infectious Diseases (CREID) will build a network of multidisciplinary researchers around the world to better understand how viruses and other pathogens make the leap from other living organisms to people.

It has long been believed that immune system dysfunction, in concert with genetic susceptibility and changes in the gut microbiome, plays a significant role in IBD. However, the types of immune cells involved and their specific contributions to IBD have remained unclear.

By conducting a comprehensive survey of phosphate group changes that occur during a SARS-CoV-2 infection, researchers have ascertained which signaling pathways were relevant, allowing them to supply mechanistic rationales for how signal-adjusting SARS-CoV-2 drugs might work.